Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outlook Therapeutics (OTLK) Tax Provisions (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Tax Provisions for 6 consecutive years, with $2800.0 as the latest value for Q1 2025.

  • On a quarterly basis, Tax Provisions changed N/A to $2800.0 in Q1 2025 year-over-year; TTM through Sep 2025 was -$3.1 million, a N/A change, with the full-year FY2025 number at $2800.0, changed 0.0% from a year prior.
  • Tax Provisions was $2800.0 for Q1 2025 at Outlook Therapeutics, up from -$2.6 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2800.0 in Q1 2025 to a low of $2800.0 in Q1 2025.